Werbung
Werbung
KPTI
Karyopharm Therapeutics Inc.
8.69
USDGesponsert
+0.52
+6.39%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
8.68
-0.01
-0.14%
KPTI Ergebnisberichte
Positives Überraschungsverhältnis
KPTI übertreffen die 24 der letzten 40Schätzungen.
60%
Nächster Bericht
Datum des nächsten Berichts
17. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$36.56M
/-$2.11
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-16.99%
/-44.76%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+19.71%
/-41.39%
Karyopharm Therapeutics Inc. earnings per share and revenue
On 03. Nov. 2025, KPTI reported earnings of -3.82 USD per share (EPS) for Q3 25, missing the estimate of -3.19 USD, resulting in a -19.63% surprise. Revenue reached 44.04 million, compared to an expected 42.04 million, with a 4.78% difference. The market reacted with a +4.66% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -2.11 USD, with revenue projected to reach 36.56 million USD, implying an decrease of -44.76% EPS, and decrease of -16.99% in Revenue from the last quarter.
FAQ
What were Karyopharm Therapeutics Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Karyopharm Therapeutics Inc. reported EPS of -$3.82, missing estimates by -19.63%, and revenue of $44.04M, 4.78% above expectations.
How did the market react to Karyopharm Therapeutics Inc.'s Q3 2025 earnings?
The stock price moved up 4.66%, changed from $5.80 before the earnings release to $6.07 the day after.
When is Karyopharm Therapeutics Inc. expected to report next?
The next earning report is scheduled for 17. Feb. 2026.
What are the forecasts for Karyopharm Therapeutics Inc.'s next earnings report?
Based on 8
analysts, Karyopharm Therapeutics Inc. is expected to report EPS of -$2.11 and revenue of $36.56M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung